AZULFIDINE

This brand name is authorized in Germany, Japan, United States

Active ingredients

The drug AZULFIDINE contains one active pharmaceutical ingredient (API):

1 Sulfasalazine
UNII 3XC8GUZ6CB - SULFASALAZINE

Therapeutic benefit of sulfasalazine appears to be due to a local action of the sulfasalazine and its split product 5-aminosalicylic acid on the mucous membrane and deeper colonic structures.

Read about Sulfasalazine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AZULFIDINE Tablet FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A07EC01 Sulfasalazine A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EC Aminosalicylic acid and similar agents
Discover more medicines within A07EC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01251483, 01923474, 04832252
Country: JP 医薬品医療機器総合機構 Identifier(s): 6219001H1056, 6219001H2036
Country: US FDA, National Drug Code Identifier(s): 0013-0101, 0013-0102

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.